Osvyrti
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Osvyrti, covering 2026-01-30 to 2026-01-30. Get the full timeline:
Most recent: EMA Authorised: Osvyrti (denosumab) — Accord Healthcare S.L.U.
1 regulatory and trial event tracked for Osvyrti, covering 2026-01-30 to 2026-01-30. Get the full timeline:
Most recent: EMA Authorised: Osvyrti (denosumab) — Accord Healthcare S.L.U.